Suhas Vasaikar
Suhas Vasaikar
Seattle Genetics
Verified email at - Homepage
Cited by
Cited by
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
SV Vasaikar, P Straub, J Wang, B Zhang
Nucleic acids research 46 (D1), D956-D963, 2018
WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
J Wang, S Vasaikar, Z Shi, M Greer, B Zhang
Nucleic acids research 45 (W1), W130-W137, 2017
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
Proteogenomic and metabolomic characterization of human glioblastoma
LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ...
Cancer cell 39 (4), 509-528. e20, 2021
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
A proteogenomic portrait of lung squamous cell carcinoma
S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ...
Cell 184 (16), 4348-4371. e40, 2021
Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing
AP Deshmukh, SV Vasaikar, K Tomczak, S Tripathi, P Den Hollander, ...
Proceedings of the National Academy of Sciences 118 (19), e2102050118, 2021
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
SV Vasaikar, AP Deshmukh, P den Hollander, S Addanki, NA Kuburich, ...
British journal of cancer 124 (1), 259-269, 2021
EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling
S Sato, S Vasaikar, A Eskaros, Y Kim, JS Lewis, B Zhang, A Zijlstra, ...
JCI insight 4 (23), 2019
Microscaled proteogenomic methods for precision oncology
S Satpathy, EJ Jaehnig, K Krug, BJ Kim, AB Saltzman, DW Chan, ...
Nature communications 11 (1), 532, 2020
Neurofibromin is an estrogen receptor-α transcriptional co-repressor in breast cancer
ZY Zheng, M Anurag, JT Lei, J Cao, P Singh, J Peng, H Kennedy, ...
Cancer cell 37 (3), 387-402. e7, 2020
Colorectal cancer cell line proteomes are representative of primary tumors and predict drug sensitivity
J Wang, D Mouradov, X Wang, RN Jorissen, MC Chambers, ...
Gastroenterology 153 (4), 1082-1095, 2017
Immune checkpoint profiles in luminal B breast cancer (Alliance)
M Anurag, M Zhu, C Huang, S Vasaikar, J Wang, J Hoog, S Burugu, ...
JNCI: Journal of the National Cancer Institute 112 (7), 737-746, 2020
Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis
AK Padhi, H Kumar, SV Vasaikar, B Jayaram, J Gomes
PLoS One 7 (2), e32479, 2012
Persistent serum protein signatures define an inflammatory subcategory of long COVID
A Talla, SV Vasaikar, GL Szeto, MP Lemos, JL Czartoski, H MacMillan, ...
Nature Communications 14 (1), 3417, 2023
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
A Talla, SV Vasaikar, MP Lemos, Z Moodie, MP Lee Pebworth, ...
BioRxiv, 2021.05. 26.442666, 2021
CpG dinucleotide frequencies reveal the role of host methylation capabilities in parvovirus evolution
M Upadhyay, J Samal, M Kandpal, S Vasaikar, B Biswas, J Gomes, ...
Journal of virology 87 (24), 13816-13824, 2013
A CTC-cluster-specific signature derived from OMICS analysis of patient-derived xenograft tumors predicts outcomes in basal-like breast cancer
H Thangavel, CD Angelis, S Vasaikar, R Bhat, MK Jolly, C Nagi, ...
Journal of clinical medicine 8 (11), 1772, 2019
The system can't perform the operation now. Try again later.
Articles 1–20